Clinical Trials Details

NRG-GY019 (Ovary/Peritoneum)

A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole VS Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

Objective

Key eligibility: Newly diagnosed Stage II-IV; includes ovary, fallopian tube and primary peritoneal; nonaberrant p53 IHC; must have had BSO; no prior treatment.

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms